Skip to content
Home/Companies/MedTech/Ionopticks

Ionopticks

MedTech·Australia·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns Ionopticks?

Ionopticks is currently owned by Adelis Equity through Adelis Equity Partners Fund IV (2024 vintage), since 2024.

Hand-verified · updated 2026-08-17

Adelis Equity
Investor
Adelis Equity
Adelis Equity Partners Fund IV · 2024 · Small-Mid Buyout

Key facts

HQAustralia
SectorMedTech
StatusActive

More from Adelis Equity Partners Fund IV

Other portfolio companies in the same fund.

Bryntum
Active
DevToolsSweden· 2025
Eitco
Active
IT ServicesGermany· 2025
Btwentyfour
Active
SaaSSweden· 2024

More Adelis Equity portfolio companies

From the same investor, across funds.

Aderian
Active
IT ServicesSweden· 2022
Avidly
Active
Business ServicesFinland· 2022
NetIP
Active
IT ServicesDenmark· 2022
Unisea
Active
SoftwareNorway· 2022
Westpack
Active
IndustrialsDenmark· 2022
Circura
Active
Business ServicesSweden· 2021

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany
Track Ionopticks

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Ionopticks?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Ionopticks.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue